Protyon (private company)

See something wrong or missing? Let us know
Offices:Groningen
Business model:B2B

Protyon is a Dutch, Groningen-based health-tech start-up developing predictive software based on computational molecular modeling and artificial intelligence (AI) to support patient-specific decision-making in the treatment of lung cancer. 

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 656k


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Protyon

Name Criteria
United Kingdom Valink Therapeutics
63%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Netherlands Nori Health
60%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Ireland Relevium
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Switzerland NextImmune
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
France Qairn
60%
  • Similar verticals: Health services, Pharma, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
United Kingdom Signatur Biosciences
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Italy Holifya
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
France AbolerIS Pharma
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Germany Atai Life Sciences
58%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Sweden Athera
58%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 1
  • At least one other investor: found 1
Top